Skip to main content
Log in

Association of serum caffeine concentrations with blood lipids in caffeine-drug users and nonusers – Results of German National Health Surveys from 1984 to 1999

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

Previous studies regarding effects of caffeine on lipids focused mainly on coffee consumption, the real association of serum caffeine concentrations with blood lipids is unclear. 814 caffeine-drug users who had taken any caffeine/caffeine-containing pharmaceutical products and 623 nonusers without any drug use in the last seven days before the medical interview were identified from German National Health Surveys from 1984 to 1999. Serum caffeine concentrations were measured by using EIA for caffeine-drug users and nonusers in the same laboratory. Blood lipids were measured routinely for all survey participants. The association of caffeine concentrations with blood lipids was established by means of partial correlation analysis and regression analysis. After controlling for influence factors, caffeine concentrations were closely positively related to triglycerides in caffeine-drug users (male r = 0.245, p  < 0.001; female: r = 0.117, p = 0.018) and related to HDL-C in female nonusers (r = 0.245, p  < 0.001). No associations were found between caffeine concentrations and total cholesterol and LDL-C levels in any groups of our study. Acute intake of caffeine might increase triglycerides levels especially in men while chronic intake of caffeine might be weakly but positively associated with HDL-C concentrations in women. The effects of caffeine on the pathogenesis of cardiovascular diseases should be further confirmed through epidemiological studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. BB Fredholm K Battig J Holmen A Nehlig EE. Zvartau (1999) ArticleTitleActions of caffeine in the brain with special reference to factors that contribute to its widespread use Pharmacol Rev 51 83–133 Occurrence Handle1:CAS:528:DyaK1MXitFWgurk%3D Occurrence Handle10049999

    CAS  PubMed  Google Scholar 

  2. PW Wilson RJ Garrison WB Kannel DL McGee WP. Castelli (1989) ArticleTitleIs coffee consumption a contributor to cardiovascular disease? Insights from the Framingham study. Arch Intern Med 149 1169–1172 Occurrence Handle1:STN:280:DyaL1M3ksF2hsA%3D%3D

    CAS  Google Scholar 

  3. TM Chou NL. Benowitz (1994) ArticleTitleCaffeine and coffee: effects on health and cardiovascular disease Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 109 173–189 Occurrence Handle10.1016/1367-8280(94)90130-9 Occurrence Handle1:STN:280:DyaK2M7oslKhsg%3D%3D Occurrence Handle7881818

    Article  CAS  PubMed  Google Scholar 

  4. A Tverdal T Stensvold K Solvoll OP Foss P Lund-Larsen K. Bjartveit (1990) ArticleTitleCoffee consumption and death from coronary heart disease in middle aged Norwegian men and women BMJ 300 566–569 Occurrence Handle1:STN:280:DyaK3c3ht12itg%3D%3D Occurrence Handle2108750 Occurrence Handle10.1136/bmj.300.6724.566

    Article  CAS  PubMed  Google Scholar 

  5. DE Grobbee EB Rimm E Giovannucci G Colditz M Stampfer W. Willett (1990) ArticleTitleCoffee, caffeine, and cardiovascular disease in men N Engl J Med 323 1026–1032 Occurrence Handle1:STN:280:DyaK3M%2FhsFajsg%3D%3D Occurrence Handle2215561 Occurrence Handle10.1056/NEJM199010113231504

    Article  CAS  PubMed  Google Scholar 

  6. SH Jee J He LJ Appel PK Whelton I Suh MJ. Klag (2001) ArticleTitleCoffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials Am J Epidemiol 153 353–362 Occurrence Handle10.1093/aje/153.4.353 Occurrence Handle1:STN:280:DC%2BD3MvgvVGjug%3D%3D Occurrence Handle11207153

    Article  CAS  PubMed  Google Scholar 

  7. BR Davis JD Curb NO Borhani RJ Prineas A. Molteni (1988) ArticleTitleCoffee consumption and serum cholesterol in the hypertension detection and follow-up program Am J Epidemiol 128 124–136 Occurrence Handle1:STN:280:DyaL1c3ltVagug%3D%3D Occurrence Handle3381821

    CAS  PubMed  Google Scholar 

  8. K Kokjohn M Graham M. McGregor (1993) ArticleTitleThe effect of coffee consumption on serum cholesterol levels J Manipulative Physiol Ther 16 327–335 Occurrence Handle1:STN:280:DyaK3szks12hsQ%3D%3D Occurrence Handle8345316

    CAS  PubMed  Google Scholar 

  9. R Urgert T Vliet Particlevan PL Zock MB. Katan (2000) ArticleTitleHeavy coffee consumption and plasma homocysteine: a randomized controlled trial in healthy volunteers Am J Clin Nutr 72 1107–1110 Occurrence Handle1:CAS:528:DC%2BD3cXnvF2nt70%3D Occurrence Handle11063436

    CAS  PubMed  Google Scholar 

  10. MR Olthof PC Hollman PL Zock MB. Katan (2001) ArticleTitleConsumption of high doses of chlorogenic acid, present in coffee, or of black tea increases plasma total homocysteine concentration in humans Am J Clin Nutr 73 532–538 Occurrence Handle1:CAS:528:DC%2BD3MXhs1Sgs74%3D Occurrence Handle11237928

    CAS  PubMed  Google Scholar 

  11. J Rooij Particlevan GH Stegen Particlevan der RC Schoemaker et al. (1995) ArticleTitleA placebo-controlled parallel study of the effect of two types of coffee oil on serum lipids and transaminases: identification of chemical substances involved in the cholesterol-raising effect of coffee Am J Clin Nutr 61 1277–1283 Occurrence Handle7762531

    PubMed  Google Scholar 

  12. MP Weusten-Vander Wouw MB Katan R Viani et al. (1994) ArticleTitleIdentity of the cholesterol-raising factor from boiled coffee and its effects on liver function enzymes J Lipid Res 35 721–733 Occurrence Handle1:CAS:528:DyaK2cXis1ymt7w%3D Occurrence Handle7911820

    CAS  PubMed  Google Scholar 

  13. B Christensen A Mosdol L Retterstol S Landaas DS. Thelle (2001) ArticleTitleAbstention from filtered coffee reduces the concentrations of plasma homocysteine and serum cholesterol – a randomized controlled trial Am J Clin Nutr 74 302–307 Occurrence Handle1:CAS:528:DC%2BD3MXms12htbg%3D Occurrence Handle11522552

    CAS  PubMed  Google Scholar 

  14. R Urgert S Meyboom M Kuilman et al. (1996) ArticleTitleComparison of effect of cafetiere and filtered coffee on serum concentrations of liver aminotransferases and lipids: six month randomised controlled trial BMJ 313 1362–1366 Occurrence Handle1:CAS:528:DyaK2sXivFShug%3D%3D Occurrence Handle8956701

    CAS  PubMed  Google Scholar 

  15. A D’Amicis C Scaccini G Tomassi M Anaclerio R Stornelli A. Bernini (1996) ArticleTitleItalian style brewed coffee: effect on serum cholesterol in young men Int J Epidemiol 25 513–520 Occurrence Handle1:STN:280:BymA38vos1Q%3D Occurrence Handle8671551

    CAS  PubMed  Google Scholar 

  16. InstitutionalAuthorNameGCP Study Group. (1988) ArticleTitleThe German Cardiovascular Prevention Study (GCP): design and methods. GCP Study Group Eur Heart J 9 1058–1066

    Google Scholar 

  17. HU Melchert B Görsch H. Hoffmeister (1995) Nichtstationäre Arzneimittelanwendung und subjektive Arzneimittelverträglichkeit in der bundesdeutschen Wohnbevölkerung der 25- bis 69jährigen: zur Epidemiologie des Arzneimittelkonsums und der unerwünschten Arzneimittelwirkungen; Ergebnisse der Erhebung des ersten Nationalen Untersuchungs-Surveys 1984–1986 MMV Medizin Verlag München

    Google Scholar 

  18. H Hoffmeister H Hüttner H Stolzenberg H Lopez J. Winkler (1992) Sozialer Status und Gesundheit: Nationaler Gesundheits-Surveys 1984–1986 MMV Medizin Verlag München

    Google Scholar 

  19. H Knopf HU. Melchert (2003) Bundes-Gesundheitssurvey: Arzneimittelgebrauch Robert Koch-Institut Berlin

    Google Scholar 

  20. WT Friedewald RI Levy DS. Fredrickson (1972) ArticleTitleEstimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 499–502 Occurrence Handle1:CAS:528:DyaE38Xkslagsbw%3D Occurrence Handle4337382

    CAS  PubMed  Google Scholar 

  21. CA Carson JA Cauley AW. Caggiula (1993) ArticleTitleRelation of caffeine intake to blood lipids in elderly women Am J Epidemiol 138 94–100 Occurrence Handle1:STN:280:DyaK3szktlWhtw%3D%3D Occurrence Handle8342534

    CAS  PubMed  Google Scholar 

  22. FA Sedor KA Schneider S. Heyden (1991) ArticleTitleEffect of coffee on cholesterol and apolipoproteins, corroborated by caffeine levels Am J Prev Med 7 391–396 Occurrence Handle1:STN:280:DyaK387mt1eqsw%3D%3D Occurrence Handle1790048

    CAS  PubMed  Google Scholar 

  23. AA Bak DE. Grobbee (1991) ArticleTitleCaffeine, blood pressure, and serum lipids Am J Clin Nutr 53 971–975 Occurrence Handle1:STN:280:DyaK3M7otFGqsA%3D%3D Occurrence Handle2008876

    CAS  PubMed  Google Scholar 

  24. J Tuomilehto A Tanskanen P Pietinen et al. (1987) ArticleTitleCoffee consumption is correlated with serum cholesterol in middle-aged Finnish men and women J Epidemiol Community Health 41 237–242 Occurrence Handle1:STN:280:DyaL1c7ntFaksQ%3D%3D Occurrence Handle3443818 Occurrence Handle10.1136/jech.41.3.237

    Article  CAS  PubMed  Google Scholar 

  25. M Dusseldorp Particlevan MB Katan T Vliet Particlevan PN Demacker AF. Stalenhoef (1991) ArticleTitleCholesterol-raising factor from boiled coffee does not pass a paper filter Arterioscler Thromb 11 586–593 Occurrence Handle2029499

    PubMed  Google Scholar 

  26. A Aro J Teirila CG. Gref (1990) ArticleTitleDose-dependent effect on serum cholesterol and apoprotein B concentrations by consumption of boiled, non-filtered coffee Atherosclerosis 83 257–261 Occurrence Handle1:STN:280:DyaK3M%2FlsVOjsA%3D%3D Occurrence Handle2242101

    CAS  PubMed  Google Scholar 

  27. M Dusseldorp Particlevan MB Katan PN. Demacker (1990) ArticleTitleEffect of decaffeinated versus regular coffee on serum lipoproteins. A 12 week double-blind trial Am J Epidemiol 132 33–40 Occurrence Handle2356812

    PubMed  Google Scholar 

  28. HR Superko PT BortzW Williams SuffixJr. JJ Albers PD. Wood (1991) ArticleTitleCaffeinated and decaffeinated coffee effects on plasma lipoprotein cholesterol, apolipoproteins, and lipase activity: a controlled, randomized trial Am J Clin Nutr 54 599–605 Occurrence Handle1:CAS:528:DyaK3MXmsFCmsLc%3D Occurrence Handle1877516

    CAS  PubMed  Google Scholar 

  29. Jacobson KA, von Lubitz DK, Daly JW, Fredholm BB. (2003) Adenosine receptor ligands: differences with acute versus chronic treatment. Trends Pharmacol Sci

  30. M Johnson-Kozlow D Kritz-Silverstein E Barrett-Connor D. Morton (2002) ArticleTitleCoffee consumption and cognitive function among older adults Am J Epidemiol 156 842–850 Occurrence Handle12397002

    PubMed  Google Scholar 

  31. E Bona U Aden BB Fredholm H. Hagberg (1995) ArticleTitleThe effect of long term caffeine reatment on hypoxic-ischemic brain damage in the neonate Pediatr Res 38 312–318 Occurrence Handle1:CAS:528:DyaK2MXosVChs78%3D Occurrence Handle7494652

    CAS  PubMed  Google Scholar 

  32. KA Rudolphi M Keil J Fastbom BB. Fredholm (1989) ArticleTitleIschaemic damage in gerbil hippocampus is reduced following upregulation of adenosine (A1) receptors by caffeine treatment Neurosci Lett 103 275–280 Occurrence Handle1:CAS:528:DyaL1MXlvVOns74%3D Occurrence Handle2812514

    CAS  PubMed  Google Scholar 

  33. A Rosengren A Dotevall L Wilhelmsen D Thelle S. Johansson (2004) ArticleTitleCoffee and incidence of diabetes in Swedish women: a prospective 18-year follow-up study J Intern Med 255 89–95 Occurrence Handle1:STN:280:DC%2BD3sngs1Sgsg%3D%3D Occurrence Handle14687243

    CAS  PubMed  Google Scholar 

  34. EE Agardh S Carlsson A Ahlbom et al. (2004) ArticleTitleCoffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women J Intern Med 255 645–652 Occurrence Handle1:STN:280:DC%2BD2c3ltVSltA%3D%3D Occurrence Handle15147528

    CAS  PubMed  Google Scholar 

  35. J Tuomilehto G Hu S Bidel J Lindstrom P. Jousilahti (2004) ArticleTitleCoffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women JAMA 291 1213–1219 Occurrence Handle1:CAS:528:DC%2BD2cXhvFOht7w%3D Occurrence Handle15010442

    CAS  PubMed  Google Scholar 

  36. GW Ross RD Abbott H Petrovitch et al. (2000) ArticleTitleAssociation of coffee and caffeine intake with the risk of Parkinson disease JAMA 283 2674–2679 Occurrence Handle1:STN:280:DC%2BD3c3otVSnug%3D%3D Occurrence Handle10819950

    CAS  PubMed  Google Scholar 

  37. A Ascherio SM Zhang MA Hernan et al. (2001) ArticleTitleProspective study of caffeine consumption and risk of Parkinson’s disease in men and women Ann Neurol 50 56–63 Occurrence Handle1:CAS:528:DC%2BD3MXlt12gurg%3D Occurrence Handle11456310

    CAS  PubMed  Google Scholar 

  38. TR Mikuls JR Cerhan LA Criswell et al. (2002) ArticleTitleCoffee, tea, and caffeine consumption and risk of rheumatoid arthritis: results from the Iowa Women’s Health Study Arthritis Rheum 46 83–91 Occurrence Handle11817612

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yong Du.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Du, Y., Melchert, HU., Knopf, H. et al. Association of serum caffeine concentrations with blood lipids in caffeine-drug users and nonusers – Results of German National Health Surveys from 1984 to 1999. Eur J Epidemiol 20, 311–316 (2005). https://doi.org/10.1007/s10654-004-7536-x

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-004-7536-x

Keywords

Navigation